ProfileGDS4718 / 214066_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 57% 49% 68% 52% 53% 51% 51% 51% 49% 53% 57% 52% 55% 56% 49% 55% 54% 53% 58% 68% 53% 55% 55% 59% 55% 52% 48% 51% 55% 53% 54% 59% 51% 52% 51% 53% 55% 49% 52% 68% 53% 54% 59% 54% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9194457
GSM549102patient 115, normal, homogenized [OPG study]5.4493149
GSM549104patient 119, normal, homogenized [OPG study]6.7927968
GSM549108patient 138, normal, homogenized [OPG study]5.6483952
GSM549119patient 077, normal, homogenized [OPG study]5.6738853
GSM549133patient 032, cancer, homogenized [OPG study]5.5489651
GSM549139patient 042, cancer, homogenized [OPG study]5.5396851
GSM549099patient 107, normal, homogenized [OPG study]5.5651351
GSM549109patient 139, normal, homogenized [OPG study]5.47649
GSM549110patient 046, normal, homogenized [OPG study]5.6801253
GSM549114patient 063, normal, homogenized [OPG study]5.9044357
GSM549122patient 082, normal, homogenized [OPG study]5.6135652
GSM549134patient 033, cancer, homogenized [OPG study]5.7693955
GSM549136patient 036, cancer, homogenized [OPG study]5.8286656
GSM549140patient 044, cancer, homogenized [OPG study]5.4547449
GSM549111patient 047, normal, homogenized [OPG study]5.8241355
GSM549113patient 057, normal, homogenized [OPG study]5.7267954
GSM549132patient 031, cancer, homogenized [OPG study]5.6727853
GSM549137patient 038, cancer, homogenized [OPG study]6.0029158
GSM549142patient 047, cancer, homogenized [OPG study]6.7223568
GSM549100patient 110, normal, homogenized [OPG study]5.7052253
GSM549107patient 135, normal, homogenized [OPG study]5.7565155
GSM549115patient 068, normal, homogenized [OPG study]5.774655
GSM549116patient 072, normal, homogenized [OPG study]6.0664459
GSM549120patient 078, normal, homogenized [OPG study]5.7793255
GSM549131patient 030, cancer, homogenized [OPG study]5.5544452
GSM549118patient 074, normal, homogenized [OPG study]5.4003848
GSM549129patient 027, cancer, homogenized [OPG study]5.6011751
GSM549123patient 088, normal, homogenized [OPG study]5.7868855
GSM549124patient 006, cancer, homogenized [OPG study]5.7054353
GSM549126patient 015, cancer, homogenized [OPG study]5.7069454
GSM549128patient 025, cancer, homogenized [OPG study]6.081359
GSM549103patient 117, normal, homogenized [OPG study]5.6125851
GSM549117patient 073, normal, homogenized [OPG study]5.5767952
GSM549138patient 041, cancer, homogenized [OPG study]5.550551
GSM549141patient 045, cancer, homogenized [OPG study]5.6664953
GSM549130patient 028, cancer, homogenized [OPG study]5.7763955
GSM549101patient 111, normal, homogenized [OPG study]5.4720749
GSM549105patient 128, normal, homogenized [OPG study]5.6188352
GSM549106patient 134, normal, homogenized [OPG study]6.7630468
GSM549112patient 048, normal, homogenized [OPG study]5.702953
GSM549125patient 011, cancer, homogenized [OPG study]5.7684454
GSM549127patient 024, cancer, homogenized [OPG study]6.1011159
GSM549135patient 035, cancer, homogenized [OPG study]5.7215254